• Premier Health (PHA) announced a 245-per-cent-increase in revenue for the second quarter of 2021
  • The company filed its condensed interim consolidated financial statements
  • The company generated revenues of $17.0 million for the quarter
  • The company attributes the increase to its full consolidation of the Code Bleu acquisition and organic growth
  • Premier Health is up 2.21 per cent, trading at $1.39 at 2:48 pm ET

Premier Health (PHA) announced a 245-per-cent-increase in revenue for the second quarter of 2021.

The Canadian healthtech company filed its condensed interim consolidated financial statements.

The company generated revenues of $17.0 million for the quarter ($30.4 million for the 6-month period compared to $8.2 million for the same period in 2020).

The company attributes the increase to its full consolidation of the Code Bleu acquisition and organic growth.

“The March offering and the latest technology roll out puts us in a very enviable position to act as an aggregator in our market,” said Premier Health CEO Martin Legault.

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals.

Premier Health is up 2.21 per cent, trading at $1.39 at 2:48 pm ET.

More From The Market Online

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.

Canada’s federal budget: What investors need to know

Canada’s federal budget in has sent ripples through the investor community, revealing shifts in fiscal policies and spending priorities.